Ⅲ类内含子及其对基因表达的影响

内含子是指断裂基因中的非编码区序列。根据内含子的核苷酸序列和RNA潜在折叠方式不同,可分成四种类型：Ⅰ类内含子、Ⅱ类内含子、Ⅲ类内含子和Ⅳ类内含子。Ⅲ类内含子为真核细胞前mRNA中的内含子。它可以启动某些基因的表达,影响基因的表达量;增加mRNA分子的稳定性;并通过选择性剪接调控基因的表达。Ⅲ类内含子可以提高转基因动物基因的表达效率。因此,基因工程中,为了提高表达效率,是选用基因组基因还是cDNA基因,应视具体基因而定。     

mRNA选择性剪接的分子机制

真核细胞mRNA前体经过剪接成为成熟的mRNA,而mRNA前体的选择性剪接极大地增加了蛋白质的多样性和基因表达的复杂程度,剪接位点的识别可以以跨越内含子的机制(内含子限定)或跨越外显子的机制(外显子限定)进行。选择性剪接有多种剪接形式：选择不同的剪接位点,选择不同的剪接末端,外显子的不同组合及内含子的剪接与否等。选择性剪接过程受到许多顺式元件和反式因子的调控,并与基本剪接过程紧密联系,剪接体中的一些剪接因子也参与了对选择性剪接的调控。选择性剪接也是1个伴随转录发生的过程,不同的启动子可调控产生不同的剪接产物。mRNA的选择性剪接机制多种多样,已发现RNA编辑和反式剪接也可参与选择性剪接过程。     

长链内含子非编码RNA在基因表达过程中的调控作用

在绝大多数人类基因中都存有非蛋白编码RNA（non-coding RNA,ncRNA）.长链内含子ncRNA（long intronic non-coding RNA,lincRNA）是众多ncRNA中的一员,而内含子区域则是具有调节性的ncRNA的关键源.长链内含子ncRNA可通过作为短链RNA的前体、或是与启动子元件的交互作用、组蛋白甲基化修饰、蛋白编码RNA选择性剪接以及蛋白质编码RNA的稳定性,从而对基因表达进行调控.至此我们可以逐步揭示出基于长链内含子ncRNA的调控系统模式.     

内含子的特异性识别与选择性剪切

剪切反应是基因选择性表达中的重要环节之一,其过程主要包括2步:去除内含子及连接外显子。依据碱基序列和潜在折叠方式的差异,内含子可分为3种类型:Ⅰ类内含子、Ⅱ类内含子、Ⅲ类内含子。其中前2类内含子能进行自我剪切,而Ⅲ类内含子的剪切反应则需由核RNA和蛋白质组成的剪接复合体介导。综述不同类别的内含子的识别与剪接机制,并对内含子在生物信息学中的应用做简要介绍。     

Ⅱ组内含子(Group Ⅱ Intron)的分布及多样性

Ⅱ组内含子(group Ⅱ intron)存在于原生生物、真菌、藻类、植物细胞器以及细菌和古细菌基因组中.在体内,Ⅱ组内含子可通过两步连续的转酯反应从前体RNA中自剪接,并连接两 侧外显子.许多Ⅱ组内含子的剪接反应是由蛋白质辅助完成的,这种蛋白质有的是由内含子编码,有的是由宿主基因编码.Ⅱ组内含子能够有效地归巢进入无内含子的等位基因,也能 够以低频率逆转座进入非等位基因.转座过程依赖内含子RNA和内含子编码的蛋白质（内切核酸酶活性和逆转录酶活性）.本论文在总结Ⅱ组内含子最新研究成果的基础上,分析Ⅱ组内含子可能的起源和进化途径     

Ⅱ组内含子(Group Ⅱ Introns)的分布及多样性

Ⅱ组内含子(groupⅡintron)存在于原生生物、真菌、藻类、植物细胞器以及细菌和古细菌基因组中.在体内,Ⅱ组内含子可通过两步连续的转酯反应从前体RNA中自剪接,并连接两侧外显子.许多Ⅱ组内含子的剪接反应是由蛋白质辅助完成的,这种蛋白质有的是由内含子编码,有的是由宿主基因编码.Ⅱ组内含子能够有效地归巢进入无内含子的等位基因,也能够以低频率逆转座进入非等位基因.转座过程依赖内含子RNA和内含子编码的蛋白质(内切核酸酶活性和逆转录酶活性).本论文在总结Ⅱ组内含子最新研究成果的基础上,分析Ⅱ组内含子可能的起源和进化途径.     

内含子对真核基因表达调控的影响

大多数真核基因都含有非编码的间隔序列--内含子,根据剪接机制的不同,可将内含子分为3类:真核mRNA内舍子、自我剪接内含子和真核tRNA内含子.在多数情况下,真核mRNA内含子的存在可以提高基因的表达水平.因为其剪接过程会影响mRNA新陈代谢的多个阶段,包括转录、RNA编辑、pre-mRNA的加工、mRNA的出核运输、翻译和无义衰变等.真核mRNA内含子在真核生物基因表达调控中起着重要的作用,是转基因研究中提高外源基因表达的重要元件之一.就真核mRNA内含子的特性、剪接机制及其对真核基因表达调控的影响作一概述.     

真核生物环形RNA编码蛋白的研究进展

环形RNA是一类广泛存在于真核细胞的内源性RNA,其由前体RNA反向剪接形成,呈闭环结构,没有5’端帽子结构及3’端polyA尾巴。一直以来,环形RNA被认为没有编码能力,不能编码蛋白质,只是作为microRNA"海绵"等方式,发挥调控功能。然而,近年来随着对环形RNA研究的不断深入,部分环形RNA被发现可通过非帽依赖翻译起始机制编码蛋白质。并且,环形RNA编码的蛋白质被证实在多个细胞过程中发挥着至关重要的作用。对目前环形RNA编码蛋白的研究现状进行综述,并对目前环形RNA编码蛋白的相关生物信息学工具进行了总结。     

表观遗传因素在RNA剪接过程中的作用

RNA剪接是真核生物基因表达过程中的重要环节,增加了蛋白质的多样性和基因表达的可调节性. 日益增多的研究表明,RNA剪接并不是独立的生物过程.RNA Ⅱ型聚合酶(RNA polymerase-Ⅱ, RNA Pol Ⅱ)、核小体定位和组蛋白修饰等因素都与RNA剪接过程密切相关.阐明RNA Pol Ⅱ、核小体定位和组蛋白修饰等因素在RNA剪接过程中的作用,将为剪接位点的准确识别和剪接调控机制的研究提供新思路.本文综述了RNA Pol Ⅱ、核小体定位和组蛋白修饰等因素对RNA剪接的影响以及它们在RNA剪接过程中的调控作用.     

鱼类基因内含子研究进展

内含子是指断裂基因中的非编码区序列,在编码蛋白质前被去除。在高等生物中,内含子的长度远大于外显子,大部分随机突变会发生在内含子中。因此,内含子的存在使高等生物对突变的耐受能力大大增强了。研究表明,内含子可以提高基因表达效率;影响RNA的转录、剪接加工、出核孔以及翻译等过程;启动某些基因的表达;并通过选择性剪接调控基因的表达。内含子功能的研究成果给当前鱼类免疫基因研究开拓了全新的视野。对内含子的分类、剪接、功能以及鱼类内含子研究的新进展进行了综述,并展望了内含子在鱼类免疫基因研究中的应用。     

ADAR-mediated RNA editing in non-coding RNA sequences

Adenosine to inosine (A-to-I) RNA editing is the most abundant editing event in animals. It converts adenosine to inosine in double-stranded RNA regions through the action of the adenosine deaminase acting on RNA (ADAR) proteins. Editing of pre-mRNA coding regions can alter the protein codon and increase functional diversity. However, most of the A-to-I editing sites occur in the non-coding regions of pre-mRNA or mRNA and non-coding RNAs. Untranslated regions (UTRs) and introns are located in pre-mRNA non-coding regions, thus A-to-I editing can influence gene expression by nuclear retention, degradation, alternative splicing, and translation regulation. Non-coding RNAs such as microRNA (miRNA), small interfering RNA (siRNA) and long non-coding RNA (lncRNA) are related to pre-mRNA splicing, translation, and gene regulation. A-to-I editing could therefore affect the stability, biogenesis, and target recognition of non-coding RNAs. Finally, it may influence the function of non-coding RNAs, resulting in regulation of gene expression. This review focuses on the function of ADAR-mediated RNA editing on mRNA non-coding regions (UTRs and introns) and non-coding RNAs (miRNA, siRNA, and lncRNA).     

RNA splicing: disease and therapy

The majority of human genes that encode proteins undergo alternative pre-mRNA splicing and mutations that affect splicing are more prevalent than previously thought. The mechanism of pre-mRNA splicing is highly complex, requiring multiple interactions between pre-mRNA, small nuclear ribonucleoproteins and splicing factor proteins. Regulation of this process is even more complicated, relying on loosely defined cis-acting regulatory sequence elements, trans-acting protein factors and cellular responses to varying environmental conditions. Many different human diseases can be caused by errors in RNA splicing or its regulation. Targeting aberrant RNA provides an opportunity to correct faulty splicing and potentially treat numerous genetic disorders. Antisense oligonucleotide therapies show particular promise in this area and, if coupled with improved delivery strategies, could open the door to a multitude of novel personalized therapies.     

Catalytic RNA and RNA Splicing

The capacity of Watson-Crick base-pair complementarity to directinformational transactions basic to gene expression has longbeen appreciated. Among RNA molecules, it mediates mRNA-tRNAcodon-anticodon pairing and the 16S rRNA-mRNA Shine-Dalgarnointeraction. More recently, we have come to realize that therole of RNA may transcend that of intermolecular recognition,per se, to include catalysis. Following the tour-de-force studiesof the self-splicing Tetrahymena rRNA precursor, the stage isnow set for the primary role of RNA to be revealed in nuclearpre-RNA splicing, which is catalyzed by a large ribonucleoprotein(RNP) complex in the cell nucleus, called the spliceosome. Theremoval of introns from nuclear pre-messenger RNA (pre-mRNA)shares fundamental properties with certain RNA self-splicingreactions. It therefore seems likely that the major catalyticstrategies in nuclear pre-mRNA splicing are carried out by thesmall nuclear RNAs (snRNAs), which are major constituents ofthe spliceosome.     

Branched RNA

The only RNA molecules known to be branched are circular structures with tails known as lariats that arise during nuclear pre-mRNA splicing. Lariats accumulate within a large multicomponent particle called a spliceosome that forms upon the addition of unspliced mRNA to nuclear extracts. Recently an RNA molecule has been observed to catalyze branch formation. In this case a single intron of a yeast mitochondrial pre-mRNA participates in a self-splicing reaction that results in the accumulation of branched lariats that are processed to correctly spliced exons. An enzyme highly specific for branch removal found in the same extracts that form branches during pre-mRNA splicing can debranch RNA lariats to their linear forms without loss of nucleotides. The chemical synthesis of branched RNA has recently been achieved. High yields of sequence-specific oligonucleotides are now available for the analysis of RNA splicing by techniques dependent on branch-site recognition.     

A new view of mRNA export: separating the wheat from the chaff

Current models for the export of messenger RNA share the notion that the highly abundant class of nuclear RNA-binding proteins--the hnRNP proteins--have a key role in exporting RNA. But recent studies have led to a new understanding of several non-hnRNP proteins, including SR proteins and the conserved mRNA export factor ALY, which are recruited to the mRNA during pre-mRNA splicing. These studies, together with older work on hnRNP particles and assembly of the spliceosome, lead us to a new view of mRNA export. In our model, the non-hnRNP factors form a splicing-dependent mRNP complex that specifically targets mature mRNA for export, while hnRNP proteins retain introns in the nucleus. A machinery that is conserved between yeast and higher eukaryotes functions to export the mRNA.     

Cellular RNA Binding Proteins NS1-BP and hnRNP K Regulate Influenza A Virus RNA Splicing

Influenza A virus is a major human pathogen with a genome comprised of eight single-strand, negative-sense, RNA segments. Two viral RNA segments, NS1 and M, undergo alternative splicing and yield several proteins including NS1, NS2, M1 and M2 proteins. However, the mechanisms or players involved in splicing of these viral RNA segments have not been fully studied. Here, by investigating the interacting partners and function of the cellular protein NS1-binding protein (NS1-BP), we revealed novel players in the splicing of the M1 segment. Using a proteomics approach, we identified a complex of RNA binding proteins containing NS1-BP and heterogeneous nuclear ribonucleoproteins (hnRNPs), among which are hnRNPs involved in host pre-mRNA splicing. We found that low levels of NS1-BP specifically impaired proper alternative splicing of the viral M1 mRNA segment to yield the M2 mRNA without affecting splicing of mRNA₃, M4, or the NS mRNA segments. Further biochemical analysis by formaldehyde and UV cross-linking demonstrated that NS1-BP did not interact directly with viral M1 mRNA but its interacting partners, hnRNPs A1, K, L, and M, directly bound M1 mRNA. Among these hnRNPs, we identified hnRNP K as a major mediator of M1 mRNA splicing. The M1 mRNA segment generates the matrix protein M1 and the M2 ion channel, which are essential proteins involved in viral trafficking, release into the cytoplasm, and budding. Thus, reduction of NS1-BP and/or hnRNP K levels altered M2/M1 mRNA and protein ratios, decreasing M2 levels and inhibiting virus replication. Thus, NS1-BP-hnRNPK complex is a key mediator of influenza A virus gene expression.